A case of skeletal and bone marrow metastases from breast cancer treated with eribulin mesylate

Author： Pashaj Etleva Cortesi Laura Proietto Manuela Bonacorsi Goretta Liardo Eliana Federico Massimo

ISSN： 1479-6694

Source： Future Oncology, Vol.9, Iss.10, 2013-10, pp. : 1437-1442

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bone marrow metastases from glioblastoma multiforme – A case report and review of the literature

By Rajagopalan Vandana Kamar Francois Thayaparan Rose Grossbard Michael

Journal of Neuro-Oncology, Vol. 72, Iss. 2, 2005-04 ,pp. : 157-161

Springer Publishing Company

Access to resources Recommend Favorite

Eribulin mesylate: a promising new antineoplastic agent for locally advanced or metastatic breast cancer

By Cortes Javier Lorca Rebeca

Future Oncology, Vol. 7, Iss. 3, 2011-03 ,pp. : 355-364

Future Medicine

Access to resources Recommend Favorite

Skeletal Metastases and Bone Marrow Infiltration from Squamous Cell Carcinoma of the Buccal Mucosa

By Mathew B.S. Jayasree K. Madhavan J. Nair M.K. Rajan B.

European Journal of Cancer. Part B: Oral Oncology, Vol. 33, Iss. 6, 1997-11 ,pp. : 454-455

Elsevier

Access to resources Recommend Favorite

Acquisition of metastatic tissue from patients with bone metastases from breast cancer

By Hilton J.

Breast Cancer Research and Treatment, Vol. 129, Iss. 3, 2011-10 ,pp. : 761-765

Springer Publishing Company

Access to resources Recommend Favorite

Trastuzumab monotherapy for bone marrow metastasis of breast cancer: A case report

Oncology Letters, Vol. 7, Iss. 6, 2014-01 ,pp. : 1951-1953

Spandidos Publications

Access to resources Recommend Favorite